title: Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats.
abstract: Transplantation therapy for human diabetes is limited by the toxicity of immunosuppressive drugs. However, even if toxicity can be minimalized, there will still be a shortage of human donor organs. Xenotransplantation of porcine islets may be a strategy to overcome these supply problems. Xenotransplantation in mesentery of pig pancreatic primordia obtained very early during organogenesis [embryonic day 28 (E28)] can obviate the need for immune suppression in rats or rhesus macaques. Here, in rats transplanted previously with E28 pig pancreatic primordia in the mesentery, we show normalization of glucose tolerance in nonimmune-suppressed streptozotocin-diabetic LEW rats and insulin and porcine proinsulin mRNA-expressing cell engraftment in the kidney following implantation of porcine islets beneath the renal capsule. Donor cell engraftment was confirmed using fluorescent in situ hybridization for the porcine X chromosome and electron microscopy. In contrast, cells from islets did not engraft in the kidney without prior transplantation of E28 pig pancreatic primordia in the mesentery. This is the first report of prolonged engraftment and sustained normalization of glucose tolerance following transplantation of porcine islets in nonimmune-suppressed, immune-competent rodents. The data are consistent with tolerance induction to a cell component of porcine islets induced by previous transplantation of E28 pig pancreatic primordia.
authors.affiliation: Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Rogers
authors.forename: Thalachallour
authors.initials: T
authors.lastname: Mohanakumar
authors.forename: Helen
authors.initials: H
authors.lastname: Liapis
authors.forename: Marc R
authors.initials: MR
authors.lastname: Hammerman
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000601:surgery*; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology / Q000601:surgery; D005260:Female; D005951:Glucose Tolerance Test; D006085:Graft Survival; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology* / Q000196:embryology*; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D051381:Rats; D011917:Rats, Inbred Lew; D034421:Sus scrofa; D014183:Transplantation, Heterologous / Q000276:immunology
chemical_list: D001786:Blood Glucose